BNBX
BNB PLUS CORP.
NASDAQ · Healthcare · Biotechnology · US
$0.16
+0.00%Latest reported
- Last report date
- May 15, 2026
- EPS actual
- -$0.68
- EPS estimate
- —
- Revenue actual
- $1.0M
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +104.2%
- Revenue beats (12Q)
- 2
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| May 15, 2026 | — | -$0.68 | — | $1.0M |
| Feb 12, 2026 | — | -$2.08 | — | $565.4K |
| Dec 22, 2025 | -$23 | -$3.17 | Beat 85.91% | $199.4K |
| Aug 14, 2025 | -$38 | $34 | Beat 190.67% | $304.4K |
| May 15, 2025 | -$45 | -$15 | Beat 65.89% | $983.4K |
| Dec 31, 2024 | -$244 | -$63 | Beat 74.23% | $1.2M |
| Jun 30, 2024 | -$371 | $1.2K | Beat 415.28% | $472.8K |
| Feb 8, 2024 | -$4.7K | -$1.4K | Beat 70.97% | $891.2K |
| Dec 7, 2023 | -$4.0K | -$3.9K | Beat 1.89% | $779.7K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of May 15, 2026